Assessing HER2 testing quality in breast cancer: variables that influence HER2 positivity rate from a large, multicenter, observational study in Germany-Reference-Cited by-同舟云学术

Assessing HER2 testing quality in breast cancer: variables that influence HER2 positivity rate from a large, multicenter, observational study in Germany

Published:2016-10-21 Issue:2 Volume:30 Page:217-226
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Rüschoff Josef, ,Lebeau Annette,Kreipe Hans,Sinn Peter,Gerharz Claus Dieter,Koch Winfried,Morris Stefanie,Ammann Johannes,Untch Michael

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2016164.pdf

Reference37 articles.

1. Wolff AC, Hammond ME, Hicks DG et al Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol 2013;31:3997–4013.

2. Slamon DJ, Clark GM, Wong SG et al Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;235:177–182.

3. Slamon DJ, Godolphin W, Jones LA et al Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989;244:707–712.

4. Hayes DF, Thor AD . C-erbB-2 in breast cancer: Development of a clinically useful marker. Semin Oncol 2001;29:231–245.

5. Cobleigh MA, Vogel CL, Tripathy D et al Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol 1999;17:2639–2648.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER2‐positive grade 1 invasive carcinomas of the breast;Histopathology;2024-09-11

2. Systematic assessment of HER2 status in ductal carcinoma in situ of the breast: a perspective on the potential clinical relevance;Breast Cancer Research;2024-08-27

3. Exploring Therapeutic Challenges in Patients with HER2-Positive Breast Cancer—A Single-Center Experience;Life;2024-08-18

4. Quality of ChatGPT-Generated Therapy Recommendations for Breast Cancer Treatment in Gynecology;Current Oncology;2024-07-01

5. Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer;Breast Cancer Research;2024-02-07